These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 20925449)

  • 1. Possible genotoxic mechanisms of nanoparticles: criteria for improved test strategies.
    Donaldson K; Poland CA; Schins RP
    Nanotoxicology; 2010 Dec; 4():414-20. PubMed ID: 20925449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Genotoxicity evaluation of nanoparticles].
    Durnev AD
    Gig Sanit; 2014; (2):76-83. PubMed ID: 25051747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
    Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
    Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale of genotoxicity testing of nanomaterials: regulatory requirements and appropriateness of available OECD test guidelines.
    Warheit DB; Donner EM
    Nanotoxicology; 2010 Dec; 4():409-13. PubMed ID: 20925448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of genotoxicity. A review of in vitro and in vivo studies with engineered nanoparticles.
    Magdolenova Z; Collins A; Kumar A; Dhawan A; Stone V; Dusinska M
    Nanotoxicology; 2014 May; 8(3):233-78. PubMed ID: 23379603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the sensitivity of the computational programs DEREK, TOPKAT, and MCASE in the prediction of the genotoxicity of pharmaceutical molecules.
    Snyder RD; Pearl GS; Mandakas G; Choy WN; Goodsaid F; Rosenblum IY
    Environ Mol Mutagen; 2004; 43(3):143-58. PubMed ID: 15065202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [General problems in the study of the mutagenic properties of drugs].
    Durnev AD; Volgareva GM; Seredenin SB
    Eksp Klin Farmakol; 1998; 61(2):4-12. PubMed ID: 9621164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic toxicity assessment: employing the best science for human safety evaluation part IV: Recommendation of a working group of the Gesellschaft fuer Umwelt-Mutationsforschung (GUM) for a simple and straightforward approach to genotoxicity testing.
    Pfuhler S; Albertini S; Fautz R; Herbold B; Madle S; Utesch D; Poth A;
    Toxicol Sci; 2007 Jun; 97(2):237-40. PubMed ID: 17303579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing strategies in mutagenicity and genetic toxicology: an appraisal of the guidelines of the European Scientific Committee for Cosmetics and Non-Food Products for the evaluation of hair dyes.
    Kirkland DJ; Henderson L; Marzin D; Müller L; Parry JM; Speit G; Tweats DJ; Williams GM
    Mutat Res; 2005 Dec; 588(2):88-105. PubMed ID: 16326131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: genotoxicity. A COLIPA analysis.
    Pfuhler S; Kirst A; Aardema M; Banduhn N; Goebel C; Araki D; Costabel-Farkas M; Dufour E; Fautz R; Harvey J; Hewitt NJ; Hibatallah J; Carmichael P; Macfarlane M; Reisinger K; Rowland J; Schellauf F; Schepky A; Scheel J
    Regul Toxicol Pharmacol; 2010; 57(2-3):315-24. PubMed ID: 20382194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the genotoxicity of chitosan nanoparticles for use in food packaging films.
    De Lima R; Feitosa L; do Espírito Santo Pereira A; de Moura MR; Ahmad Aouada F; Henrique Capparelli Mattoso L; Fernandes Fraceto L
    J Food Sci; 2010 Aug; 75(6):N89-96. PubMed ID: 20722945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Report of the IWGT working group on strategies and interpretation of regulatory in vivo tests I. Increases in micronucleated bone marrow cells in rodents that do not indicate genotoxic hazards.
    Tweats DJ; Blakey D; Heflich RH; Jacobs A; Jacobsen SD; Morita T; Nohmi T; O'Donovan MR; Sasaki YF; Sofuni T; Tice R;
    Mutat Res; 2007 Feb; 627(1):78-91. PubMed ID: 17116417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineered nanoparticles may induce genotoxicity.
    Wang H; Wu F; Meng W; White JC; Holden PA; Xing B
    Environ Sci Technol; 2013; 47(23):13212-4. PubMed ID: 24228618
    [No Abstract]   [Full Text] [Related]  

  • 14. Latest advances in computational genotoxicity prediction.
    Naven RT; Greene N; Williams RV
    Expert Opin Drug Metab Toxicol; 2012 Dec; 8(12):1579-87. PubMed ID: 22998164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
    Kirkland D; Aardema M; Henderson L; Müller L
    Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of high-throughput genotoxicity assays used in profiling the US EPA ToxCast chemicals.
    Knight AW; Little S; Houck K; Dix D; Judson R; Richard A; McCarroll N; Akerman G; Yang C; Birrell L; Walmsley RM
    Regul Toxicol Pharmacol; 2009 Nov; 55(2):188-99. PubMed ID: 19591892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the relevance of genotoxicity for fish populations II: genotoxic effects in zebrafish (Danio rerio) exposed to 4-nitroquinoline-1-oxide in a complete life-cycle test.
    Diekmann M; Waldmann P; Schnurstein A; Grummt T; Braunbeck T; Nagel R
    Aquat Toxicol; 2004 May; 68(1):27-37. PubMed ID: 15110467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-specificity and high-sensitivity genotoxicity assessment in a human cell line: validation of the GreenScreen HC GADD45a-GFP genotoxicity assay.
    Hastwell PW; Chai LL; Roberts KJ; Webster TW; Harvey JS; Rees RW; Walmsley RM
    Mutat Res; 2006 Sep; 607(2):160-75. PubMed ID: 16781187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategy for genotoxicity testing--metabolic considerations.
    Ku WW; Bigger A; Brambilla G; Glatt H; Gocke E; Guzzie PJ; Hakura A; Honma M; Martus HJ; Obach RS; Roberts S;
    Mutat Res; 2007 Feb; 627(1):59-77. PubMed ID: 17141553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic toxicity assessment: employing the best science for human safety evaluation Part VII: Why not start with a single test: a transformational alternative to genotoxicity hazard and risk assessment.
    Ku WW; Aubrecht J; Mauthe RJ; Schiestl RH; Fornace AJ
    Toxicol Sci; 2007 Sep; 99(1):20-5. PubMed ID: 17548889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.